292 related articles for article (PubMed ID: 20621253)
1. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease.
Saha SA; Tuttle KR
Cardiol Clin; 2010 Aug; 28(3):497-516. PubMed ID: 20621253
[TBL] [Abstract][Full Text] [Related]
2. [Possibilities and limits of oral diabetes therapy].
Bruneder H
Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
[No Abstract] [Full Text] [Related]
3. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
Hemmingsen B; Lund SS; Vaag A
Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
[TBL] [Abstract][Full Text] [Related]
4. Treating type 2 diabetes: targeting the many causative factors.
Sutherland JE; Hoehns JD
J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823
[No Abstract] [Full Text] [Related]
5. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
Fövényi J
Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874
[No Abstract] [Full Text] [Related]
6. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
Standl E; Schnell O
Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
[No Abstract] [Full Text] [Related]
7. Insulin in the early management of diabetic complications.
Miles JM
J Assoc Physicians India; 2003 May; 51():501-5. PubMed ID: 12974435
[TBL] [Abstract][Full Text] [Related]
8. [Long term efficacy and tolerance of antidiabetic treatments. New data].
Mirouze J
Nouv Presse Med; 1974 Jun; 3(24):1551-4. PubMed ID: 4211493
[No Abstract] [Full Text] [Related]
9. Oral hypoglycaemic agents.
Borthwick LJ; Stowers JM
Practitioner; 1979 Mar; 222(1329):358-66. PubMed ID: 450836
[No Abstract] [Full Text] [Related]
10. Glycemic control and treatment patterns in patients with heart failure.
Tang WH
Heart Fail Monit; 2006; 5(1):10-4. PubMed ID: 16547530
[TBL] [Abstract][Full Text] [Related]
11. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
Malesker MA
Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
[TBL] [Abstract][Full Text] [Related]
12. [Differential therapy using oral antidiabetics].
Mehnert H
Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
[No Abstract] [Full Text] [Related]
13. Controlling diabetes with diet and oral hypoglycemic agents.
Faludi G
Geriatrics; 1976 Oct; 31(10):67-70. PubMed ID: 964602
[No Abstract] [Full Text] [Related]
14. [Oral hypoglycemic therapy of diabetes mellitus].
Montenero P
Minerva Med; 1976 Jan; 67(3):208-15. PubMed ID: 1250219
[No Abstract] [Full Text] [Related]
15. [Diabetes therapy using oral antidiabetics].
Hasslacher C; Wahl P
Z Allgemeinmed; 1972 Apr; 48(12):583-7. PubMed ID: 5034166
[No Abstract] [Full Text] [Related]
16. Pharmacologic management of diabetes mellitus.
Mozersky RP
J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525
[TBL] [Abstract][Full Text] [Related]
17. Therapy for type 2 diabetes mellitus.
Elson DF; Meredith M
WMJ; 1998 Mar; 97(3):49-54. PubMed ID: 9540451
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
Ninni M; Castelletta L
Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364
[No Abstract] [Full Text] [Related]
19. Editorial: Oral therapy in diabetes mellitus.
Scoville AB
South Med J; 1974 Jun; 67(6):635-8. PubMed ID: 4208385
[No Abstract] [Full Text] [Related]
20. [Round table talk about therapy of diabetes in Scandinavia. Surprising differences in the choice of therapy. Too little diet, too much tablets?].
Karlsson Y
Nord Med; 1976 Jun; 91(6-7-1):171-81. PubMed ID: 934791
[No Abstract] [Full Text] [Related]
[Next] [New Search]